Associate II - Quality Assurance
Catalent
About this role
An Associate II in Quality Assurance at Catalent based in Madison, WI, working onsite within a large biologics biomanufacturing facility. The role is part of the Quality Assurance Systems group supporting the company’s drug development and delivery operations. It is an entry-level position within a global pharmaceutical organization focused on maintaining quality across manufacturing and analytical services.
Skills
Qualifications
About Catalent
catalent.comCatalent delivers end-to-end pharma solutions as a trusted CDMO, advancing drug development and manufacturing worldwide. Partner with us today!
Recent company news
Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
3 days ago
Inspection issues remain at Catalent Indiana plant, pharma companies say
1 day ago
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
3 days ago
Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
3 weeks ago
Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPS
1 day ago
About Catalent
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Catalent.
Salary
$65k – $87k
per year
More jobs at Catalent
Similar Jobs
Associate II, Quality Assurance
Resilience
Assistant Manager- Quality Management System (Analytical Assurance)
Zentiva
Quality Assurance Associate II
Minaris Advanced Therapies
Quality Assurance Scientist II
Cepheid
Associate Scientist II, Biologics Drug Product Development
AbbVie
Scientist I/Associate Scientist II, Biologics Drug Product Development
AbbVie